Annexon Offers A High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases

Core Insights - Systemic complement-mediated diseases are relatively rare, but complement overactivation significantly impacts a broader range of hard-to-treat diseases, affecting quality of life [1] Group 1 - Complement overactivation plays a significant role in various diseases that are challenging to treat [1] - These diseases often have serious implications for patients' quality of life [1]